Evidence map›Paper›PMID 33812879›Full record

ArticleUrology2021

"The Back-up Vasectomy Reversal." Simultaneous Sperm Retrieval and Vasectomy Reversal in the Couple With Advanced Maternal Age: A Cost-Effectiveness Analysis.

Philip J Cheng, Jaewhan Kim, James R Craig, Joseph Alukal, Alexander W Pastuszak, Thomas J Walsh, James M Hotaling

Abstract read
PubMed Publisher
In one paragraph

Article in Urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Philip J ChengReproductive Medicine Associates of New Jersey, Basking Ridge, NJ, Rutgers Robert Wood Johnson Medical School, Department of Obstetrics, Gynecology, and Reproductive Sciences. Electronic address: pcheng@ivirma.com.
Jaewhan KimDepartment of Health and Kinesiology, University of Utah, Salt Lake City, UT.
James R CraigFontana Medical Center, Kaiser Permanente, Fontana, CA.
Joseph AlukalDepartment of Urology, Columbia University Medical Center, New York, NY.
Alexander W PastuszakDivision of Urology, University of Utah, Salt Lake City, UT.
Thomas J WalshDepartment of Urology, University of Washington, Seattle, WA.
James M HotalingDivision of Urology, University of Utah, Salt Lake City, UT, Reproductive Medicine Associates of New Jersey.
University of Utah · USColumbia University Irving Medical Center · USKaiser Permanente Fontana Medical Center · USReproductive Medicine Associates of New Jersey · USRutgers, The State University of New Jersey · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the cost-effectiveness of different fertility options in men who have undergone vasectomy in couples with a female of advanced maternal age (AMA). The options include vasectomy reversal (VR), sperm retrieval (SR) with in vitro fertilization (IVF), and the combination of VR and SR with IVF, which is a treatment pathway that has been understudied. MATERIALS AND

methodsUsing TreeAge software, a model-based cost-utility analysis was performed estimating the cost per quality-adjusted life years (QALY) in couples with infertility due to vasectomy and advanced female age over a period of one year. The model stratified for female age (35-37, 38-40, >40) and evaluated four strategies: VR followed by natural conception (NC), SR with IVF, VR and SR followed by failed NC and then IVF, and VR and SR followed by failed IVF and then NC. QALY estimates and outcome probabilities were obtained from the literature and average patient charges were calculated from high-volume centers.

resultsThe most cost-effective fertility strategy was to undergo VR and try for NC (cost-per-QALY: $7,150 (35-37 y), $7,203 (38-40 y), and $7,367 (>40 y)). The second most cost-effective strategy was the "back-up vasectomy reversal": undergo VR and SR, attempt IVF and switch to NC if IVF fails.

conclusionIn couples with a history of vasectomy and female of AMA, it is most cost-effective to undergo a VR. If the couple opts for SR for IVF, it is more cost-effective to undergo a concomitant VR than SR alone.

Indexed as

Maternal AgeVasectomyAdultCost-Benefit AnalysisFemaleFertilization in VitroHumansMaleQuality-Adjusted Life YearsReoperationReproductive HealthReproductive Health ServicesReproductive Techniques, AssistedSperm Retrieval

Identifiers

PMID33812879
OpenAlexW3150253222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.